HEADER CARBOHYDRATE 21-SEP-21 7PR8 TITLE CRYSTAL STRUCTURE OF HUMAN HEPARANASE IN COMPLEX WITH COVALENT TITLE 2 INHIBITOR GR109 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPARANASE 50 KDA SUBUNIT; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: HEPARANASE 8 KDA SUBUNIT; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HPSE, HEP, HPA, HPA1, HPR1, HPSE1, HSE1; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: HPSE, HEP, HPA, HPA1, HPR1, HPSE1, HSE1; SOURCE 13 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 7111 KEYWDS GLYCOSIDE HYDROLASE, CARBOHYDRATE, GLUCURONIDASE, GH79, HEPARAN KEYWDS 2 SULFATE EXPDTA X-RAY DIFFRACTION AUTHOR L.WU,Z.ARMSTRONG,G.J.DAVIES REVDAT 3 09-OCT-24 7PR8 1 REMARK REVDAT 2 31-JAN-24 7PR8 1 REMARK REVDAT 1 03-AUG-22 7PR8 0 JRNL AUTH C.DE BOER,Z.ARMSTRONG,V.A.J.LIT,U.BARASH,G.RUIJGROK, JRNL AUTH 2 I.BOYANGO,M.M.WEITZENBERG,S.P.SCHRODER,A.J.C.SARRIS, JRNL AUTH 3 N.J.MEEUWENOORD,P.BULE,Y.KAYAL,N.ILAN,J.D.C.CODEE, JRNL AUTH 4 I.VLODAVSKY,H.S.OVERKLEEFT,G.J.DAVIES,L.WU JRNL TITL MECHANISM-BASED HEPARANASE INHIBITORS REDUCE CANCER JRNL TITL 2 METASTASIS IN VIVO. JRNL REF PROC.NATL.ACAD.SCI.USA V. 119 67119 2022 JRNL REFN ESSN 1091-6490 JRNL PMID 35881786 JRNL DOI 10.1073/PNAS.2203167119 REMARK 2 REMARK 2 RESOLUTION. 1.66 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.66 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.37 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 59921 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.167 REMARK 3 FREE R VALUE : 0.194 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.052 REMARK 3 FREE R VALUE TEST SET COUNT : 3027 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.66 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.70 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4104 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.73 REMARK 3 BIN R VALUE (WORKING SET) : 0.3320 REMARK 3 BIN FREE R VALUE SET COUNT : 241 REMARK 3 BIN FREE R VALUE : 0.3430 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3643 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 122 REMARK 3 SOLVENT ATOMS : 308 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.61100 REMARK 3 B22 (A**2) : -2.02200 REMARK 3 B33 (A**2) : -0.89400 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.75900 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.091 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.089 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.084 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.738 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.976 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.967 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3932 ; 0.010 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 3749 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5342 ; 1.694 ; 1.696 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8665 ; 1.375 ; 1.618 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 467 ; 6.809 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 183 ;33.121 ;21.858 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 654 ;12.135 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 22 ;11.093 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 515 ; 0.280 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4850 ; 0.009 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 904 ; 0.003 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 740 ; 0.205 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 61 ; 0.248 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1907 ; 0.171 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 242 ; 0.159 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1859 ; 2.921 ; 3.471 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1858 ; 2.917 ; 3.468 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2329 ; 3.932 ; 5.189 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2330 ; 3.933 ; 5.191 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2073 ; 4.095 ; 4.013 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2074 ; 4.094 ; 4.014 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 3013 ; 6.087 ; 5.818 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 3014 ; 6.086 ; 5.820 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK BULK SOLVENT REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THEIR REMARK 3 RIDING POSITIONS REMARK 4 REMARK 4 7PR8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 23-SEP-21. REMARK 100 THE DEPOSITION ID IS D_1292118229. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-NOV-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97933 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 XE 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2 REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 59928 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.660 REMARK 200 RESOLUTION RANGE LOW (A) : 39.370 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 4.200 REMARK 200 R MERGE (I) : 0.05200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.66 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.70 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 1.41500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: 5E8M REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.35 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.53 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M MES PH 5.5, 0.1 M MGCL2, 17% REMARK 280 PEG3350, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 35.64500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 10990 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19180 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -29.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HH21 ARG A 307 O1 EDO A 605 1.56 REMARK 500 HD21 ASN A 178 O HOH A 704 1.58 REMARK 500 HD22 ASN B 64 O HOH B 202 1.60 REMARK 500 O HOH A 864 O HOH A 894 2.15 REMARK 500 OE2 GLU A 308 O HOH A 701 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 258 77.58 -105.03 REMARK 500 THR A 333 -46.61 -130.84 REMARK 500 GLU A 343 118.01 -167.56 REMARK 500 LEU A 355 -50.77 -123.66 REMARK 500 ASN A 390 16.79 -140.62 REMARK 500 LEU A 419 -156.64 -116.71 REMARK 500 PRO A 469 41.82 -97.44 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 959 DISTANCE = 6.15 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7PR7 RELATED DB: PDB REMARK 900 7PR7 CONTAINS THE SAME PROTEIN IN COMPLEX WITH A RELATED LIGAND DBREF 7PR8 A 160 543 UNP Q9Y251 HPSE_HUMAN 160 543 DBREF 7PR8 B 36 109 UNP Q9Y251 HPSE_HUMAN 36 109 SEQADV 7PR8 LYS A 159 UNP Q9Y251 EXPRESSION TAG SEQADV 7PR8 ARG A 307 UNP Q9Y251 LYS 307 VARIANT SEQRES 1 A 385 LYS PHE LYS ASN SER THR TYR SER ARG SER SER VAL ASP SEQRES 2 A 385 VAL LEU TYR THR PHE ALA ASN CYS SER GLY LEU ASP LEU SEQRES 3 A 385 ILE PHE GLY LEU ASN ALA LEU LEU ARG THR ALA ASP LEU SEQRES 4 A 385 GLN TRP ASN SER SER ASN ALA GLN LEU LEU LEU ASP TYR SEQRES 5 A 385 CYS SER SER LYS GLY TYR ASN ILE SER TRP GLU LEU GLY SEQRES 6 A 385 ASN GLU PRO ASN SER PHE LEU LYS LYS ALA ASP ILE PHE SEQRES 7 A 385 ILE ASN GLY SER GLN LEU GLY GLU ASP PHE ILE GLN LEU SEQRES 8 A 385 HIS LYS LEU LEU ARG LYS SER THR PHE LYS ASN ALA LYS SEQRES 9 A 385 LEU TYR GLY PRO ASP VAL GLY GLN PRO ARG ARG LYS THR SEQRES 10 A 385 ALA LYS MET LEU LYS SER PHE LEU LYS ALA GLY GLY GLU SEQRES 11 A 385 VAL ILE ASP SER VAL THR TRP HIS HIS TYR TYR LEU ASN SEQRES 12 A 385 GLY ARG THR ALA THR ARG GLU ASP PHE LEU ASN PRO ASP SEQRES 13 A 385 VAL LEU ASP ILE PHE ILE SER SER VAL GLN LYS VAL PHE SEQRES 14 A 385 GLN VAL VAL GLU SER THR ARG PRO GLY LYS LYS VAL TRP SEQRES 15 A 385 LEU GLY GLU THR SER SER ALA TYR GLY GLY GLY ALA PRO SEQRES 16 A 385 LEU LEU SER ASP THR PHE ALA ALA GLY PHE MET TRP LEU SEQRES 17 A 385 ASP LYS LEU GLY LEU SER ALA ARG MET GLY ILE GLU VAL SEQRES 18 A 385 VAL MET ARG GLN VAL PHE PHE GLY ALA GLY ASN TYR HIS SEQRES 19 A 385 LEU VAL ASP GLU ASN PHE ASP PRO LEU PRO ASP TYR TRP SEQRES 20 A 385 LEU SER LEU LEU PHE LYS LYS LEU VAL GLY THR LYS VAL SEQRES 21 A 385 LEU MET ALA SER VAL GLN GLY SER LYS ARG ARG LYS LEU SEQRES 22 A 385 ARG VAL TYR LEU HIS CYS THR ASN THR ASP ASN PRO ARG SEQRES 23 A 385 TYR LYS GLU GLY ASP LEU THR LEU TYR ALA ILE ASN LEU SEQRES 24 A 385 HIS ASN VAL THR LYS TYR LEU ARG LEU PRO TYR PRO PHE SEQRES 25 A 385 SER ASN LYS GLN VAL ASP LYS TYR LEU LEU ARG PRO LEU SEQRES 26 A 385 GLY PRO HIS GLY LEU LEU SER LYS SER VAL GLN LEU ASN SEQRES 27 A 385 GLY LEU THR LEU LYS MET VAL ASP ASP GLN THR LEU PRO SEQRES 28 A 385 PRO LEU MET GLU LYS PRO LEU ARG PRO GLY SER SER LEU SEQRES 29 A 385 GLY LEU PRO ALA PHE SER TYR SER PHE PHE VAL ILE ARG SEQRES 30 A 385 ASN ALA LYS VAL ALA ALA CYS ILE SEQRES 1 B 74 GLN ASP VAL VAL ASP LEU ASP PHE PHE THR GLN GLU PRO SEQRES 2 B 74 LEU HIS LEU VAL SER PRO SER PHE LEU SER VAL THR ILE SEQRES 3 B 74 ASP ALA ASN LEU ALA THR ASP PRO ARG PHE LEU ILE LEU SEQRES 4 B 74 LEU GLY SER PRO LYS LEU ARG THR LEU ALA ARG GLY LEU SEQRES 5 B 74 SER PRO ALA TYR LEU ARG PHE GLY GLY THR LYS THR ASP SEQRES 6 B 74 PHE LEU ILE PHE ASP PRO LYS LYS GLU HET NAG C 1 27 HET FUC C 2 21 HET 8I4 D 1 42 HET NGY D 2 62 HET NAG A 601 28 HET NAG A 602 28 HET NAG A 603 28 HET EDO A 604 10 HET EDO A 605 10 HET EDO A 606 10 HET EDO A 607 10 HET EDO A 608 10 HET EDO A 609 10 HET CL A 610 1 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM 8I4 (2R,3S,5R,6R)-2,3,4,5,6-PENTAKIS(OXIDANYL)CYCLOHEXANE- HETNAM 2 8I4 1-CARBOXYLIC ACID HETNAM NGY 2-ACETAMIDO-2-DEOXY-6-O-SULFO-ALPHA-D-GLUCOPYRANOSE HETNAM EDO 1,2-ETHANEDIOL HETNAM CL CHLORIDE ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE HETSYN 8I4 (2R)-5-[(E)-2-(2,4-DINITROPHENYL)ETHENYL]-2-[(1R)-2- HETSYN 2 8I4 OXIDANYL-2-OXIDANYLIDENE-1-(2-THIOPHEN-2- HETSYN 3 8I4 YLETHANOYLAMINO)ETHYL]-3,6-DIHYDRO-2H-1,3-THIAZINE-4- HETSYN 4 8I4 CARBOXYLIC ACID HETSYN NGY 2-(ACETYLAMINO)-2-DEOXY-6-O-SULFO-ALPHA-D- HETSYN 2 NGY GLUCOPYRANOSE; N-ACETYL-6-O-SULFO-ALPHA-D-GLUCOSAMINE; HETSYN 3 NGY 2-ACETAMIDO-2-DEOXY-6-O-SULFO-ALPHA-D-GLUCOSE; 2- HETSYN 4 NGY ACETAMIDO-2-DEOXY-6-O-SULFO-D-GLUCOSE; 2-ACETAMIDO-2- HETSYN 5 NGY DEOXY-6-O-SULFO-GLUCOSE HETSYN EDO ETHYLENE GLYCOL FORMUL 3 NAG 4(C8 H15 N O6) FORMUL 3 FUC C6 H12 O5 FORMUL 4 8I4 C7 H12 O7 FORMUL 4 NGY C8 H15 N O9 S FORMUL 8 EDO 6(C2 H6 O2) FORMUL 14 CL CL 1- FORMUL 15 HOH *308(H2 O) HELIX 1 AA1 SER A 166 SER A 180 1 15 HELIX 2 AA2 SER A 201 LYS A 214 1 14 HELIX 3 AA3 GLU A 225 ASN A 227 5 3 HELIX 4 AA4 SER A 228 ASP A 234 1 7 HELIX 5 AA5 ASN A 238 LYS A 255 1 18 HELIX 6 AA6 ARG A 272 GLY A 287 1 16 HELIX 7 AA7 THR A 306 LEU A 311 1 6 HELIX 8 AA8 ASN A 312 SER A 332 1 21 HELIX 9 AA9 THR A 358 ALA A 360 5 3 HELIX 10 AB1 ALA A 361 GLY A 376 1 16 HELIX 11 AB2 LEU A 401 LEU A 413 1 13 HELIX 12 AB3 HIS A 486 SER A 490 5 5 HELIX 13 AB4 VAL A 539 ILE A 543 5 5 HELIX 14 AB5 ASP B 62 ASP B 68 5 7 HELIX 15 AB6 ARG B 70 SER B 77 1 8 HELIX 16 AB7 SER B 77 LEU B 87 1 11 HELIX 17 AB8 GLY B 96 ASP B 100 5 5 SHEET 1 AA1 2 SER A 163 TYR A 165 0 SHEET 2 AA1 2 LEU B 102 PHE B 104 1 O ILE B 103 N SER A 163 SHEET 1 AA2 9 LEU A 182 LEU A 188 0 SHEET 2 AA2 9 SER A 219 LEU A 222 1 O SER A 219 N PHE A 186 SHEET 3 AA2 9 LEU A 263 VAL A 268 1 O TYR A 264 N TRP A 220 SHEET 4 AA2 9 SER A 292 ASN A 301 1 O HIS A 296 N VAL A 268 SHEET 5 AA2 9 LYS A 338 TYR A 348 1 O TRP A 340 N VAL A 293 SHEET 6 AA2 9 VAL A 379 ARG A 382 1 O VAL A 379 N LEU A 341 SHEET 7 AA2 9 LEU B 57 ILE B 61 1 O SER B 58 N VAL A 380 SHEET 8 AA2 9 ALA B 90 PHE B 94 1 O ARG B 93 N ILE B 61 SHEET 9 AA2 9 LEU A 182 LEU A 188 1 N ILE A 185 O PHE B 94 SHEET 1 AA3 4 LEU A 498 THR A 499 0 SHEET 2 AA3 4 VAL A 493 LEU A 495 -1 N LEU A 495 O LEU A 498 SHEET 3 AA3 4 VAL A 475 PRO A 482 -1 N ARG A 481 O GLN A 494 SHEET 4 AA3 4 LYS A 514 PRO A 515 -1 O LYS A 514 N LYS A 477 SHEET 1 AA4 8 LEU A 498 THR A 499 0 SHEET 2 AA4 8 VAL A 493 LEU A 495 -1 N LEU A 495 O LEU A 498 SHEET 3 AA4 8 VAL A 475 PRO A 482 -1 N ARG A 481 O GLN A 494 SHEET 4 AA4 8 SER A 528 ILE A 534 -1 O PHE A 531 N TYR A 478 SHEET 5 AA4 8 LEU A 450 ASN A 456 -1 N LEU A 452 O PHE A 532 SHEET 6 AA4 8 LEU A 431 THR A 438 -1 N HIS A 436 O THR A 451 SHEET 7 AA4 8 VAL A 414 VAL A 418 -1 N GLY A 415 O CYS A 437 SHEET 8 AA4 8 HIS B 50 LEU B 51 -1 O HIS B 50 N VAL A 418 SHEET 1 AA5 4 MET A 420 VAL A 423 0 SHEET 2 AA5 4 VAL B 38 PHE B 44 -1 O ASP B 42 N SER A 422 SHEET 3 AA5 4 LYS A 462 ARG A 465 1 N TYR A 463 O VAL B 39 SHEET 4 AA5 4 LEU A 522 LEU A 524 -1 O LEU A 524 N LYS A 462 SSBOND 1 CYS A 437 CYS A 542 1555 1555 2.04 LINK ND2 ASN A 162 C1 NAG A 601 1555 1555 1.44 LINK ND2 ASN A 200 C1 NAG A 602 1555 1555 1.45 LINK ND2 ASN A 238 C1 NAG A 603 1555 1555 1.47 LINK OE2 GLU A 343 C1 B8I4 D 1 1555 1555 1.39 LINK OE2 GLU A 343 C1 A8I4 D 1 1555 1555 1.40 LINK ND2 ASN A 459 C1 NAG C 1 1555 1555 1.48 LINK O6 NAG C 1 C1 FUC C 2 1555 1555 1.45 LINK O4 A8I4 D 1 C1 ANGY D 2 1555 1555 1.43 LINK O4 B8I4 D 1 C1 BNGY D 2 1555 1555 1.44 CISPEP 1 GLY A 265 PRO A 266 0 0.39 CISPEP 2 GLN A 383 VAL A 384 0 -2.59 CISPEP 3 TYR A 468 PRO A 469 0 -2.14 CISPEP 4 GLY A 484 PRO A 485 0 4.73 CISPEP 5 SER B 88 PRO B 89 0 3.14 CRYST1 46.490 71.290 79.070 90.00 95.20 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021510 0.000000 0.001958 0.00000 SCALE2 0.000000 0.014027 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012699 0.00000